The Board of Scancell Holdings Plc, (AIM: SCLP), the developer of therapeutic cancer vaccines, announce the appointment of Matrix Corporate Capital LLP as joint broker with immediate effect.
For further information contact:
Professor Lindy Durrant - Scancell Holdings Plc
John Bick/Kirsty Corcoran - Hansard Communications
Ross Andrews/Tom Rowley - Zeus Capital - Nominated Adviser/Joint Broker
Robert Naylor/Stephen Waterman - Matrix Corporate Capital LLP - Joint Broker
View the full Document
Monday 6 September 2010 13:00